M

MITech Co Ltd
KOSDAQ:179290

Watchlist Manager
MITech Co Ltd
KOSDAQ:179290
Watchlist
Price: 7 990 KRW -1.36% Market Closed
Market Cap: 258.6B KRW
Have any thoughts about
MITech Co Ltd?
Write Note

MITech Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MITech Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
M
MITech Co Ltd
KOSDAQ:179290
Cash from Operating Activities
â‚©17.8B
CAGR 3-Years
66%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Dentium Co Ltd
KRX:145720
Cash from Operating Activities
â‚©28.2B
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Biodyne Co Ltd
KOSDAQ:314930
Cash from Operating Activities
â‚©405m
CAGR 3-Years
52%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Cash from Operating Activities
â‚©29.9B
CAGR 3-Years
60%
CAGR 5-Years
248%
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Cash from Operating Activities
â‚©95.1B
CAGR 3-Years
27%
CAGR 5-Years
23%
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Cash from Operating Activities
â‚©6.2B
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
3%
No Stocks Found

MITech Co Ltd
Glance View

Market Cap
258.6B KRW
Industry
Health Care

M.I.Tech Co., Ltd. develops and manufactures non-vascular stent system. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 157 full-time employees. The company went IPO on 2018-11-29. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company’s stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
12 159.45 KRW
Undervaluation 34%
Intrinsic Value
Price
M

See Also

What is MITech Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
17.8B KRW

Based on the financial report for Dec 31, 2023, MITech Co Ltd's Cash from Operating Activities amounts to 17.8B KRW.

What is MITech Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
54%

Over the last year, the Cash from Operating Activities growth was 107%. The average annual Cash from Operating Activities growth rates for MITech Co Ltd have been 66% over the past three years , 54% over the past five years .

Back to Top